Cargando…

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type

OBJECTIVE: Diagnoses of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) are common, but the corresponding risk of disease varies by human papillomavirus (HPV) status, complicating management strategies. Our aim was to estimate the lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Maria, Elfström, K. Miriam, Olsson, Sven-Erik, Dillner, Joakim, Andersson, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471160/
https://www.ncbi.nlm.nih.gov/pubmed/26083247
http://dx.doi.org/10.1371/journal.pone.0127444
_version_ 1782376858460880896
author Persson, Maria
Elfström, K. Miriam
Olsson, Sven-Erik
Dillner, Joakim
Andersson, Sonia
author_facet Persson, Maria
Elfström, K. Miriam
Olsson, Sven-Erik
Dillner, Joakim
Andersson, Sonia
author_sort Persson, Maria
collection PubMed
description OBJECTIVE: Diagnoses of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) are common, but the corresponding risk of disease varies by human papillomavirus (HPV) status, complicating management strategies. Our aim was to estimate the longer-term risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) among women with ASCUS/LSIL by age, HPV status, and genotype(s). METHODS: A total of 314 women with ASCUS/ LSIL were followed for a median of 3.8 years. Baseline HPV status was determined by reflex testing and women with histologically confirmed CIN2+ were identified through linkage to the Swedish National Quality Register for Cervical Cancer Prevention. Cumulative incidence and hazard ratios were estimated to explore differences between index data and associations with CIN2+. RESULTS: In total, 89 women (28.3%) developed CIN2+. High-risk (HR) HPV-positive women developed significantly more CIN2+ than HR-HPV-negative women (cumulative incidence 3.5 years after the index test: 42.2%, 95% CI: 32.5–53.5 for HPV16/18; 36.2%, 95% CI: 28.3–45.4 for other HR-HPV types; and 2.0%, 95% CI: 0.5–7.8 for HR-HPV-negative women; p<0.0001). CONCLUSION: HPV status was of greatest importance in determining the risk of CIN2+. The risk was low among HPV-negative women during the first years of follow-up, suggesting these women could be followed less intensively. HPV16/18-positive women may need intensified follow-up as they showed the highest risk of CIN2+.
format Online
Article
Text
id pubmed-4471160
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44711602015-06-29 Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type Persson, Maria Elfström, K. Miriam Olsson, Sven-Erik Dillner, Joakim Andersson, Sonia PLoS One Research Article OBJECTIVE: Diagnoses of atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) are common, but the corresponding risk of disease varies by human papillomavirus (HPV) status, complicating management strategies. Our aim was to estimate the longer-term risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) among women with ASCUS/LSIL by age, HPV status, and genotype(s). METHODS: A total of 314 women with ASCUS/ LSIL were followed for a median of 3.8 years. Baseline HPV status was determined by reflex testing and women with histologically confirmed CIN2+ were identified through linkage to the Swedish National Quality Register for Cervical Cancer Prevention. Cumulative incidence and hazard ratios were estimated to explore differences between index data and associations with CIN2+. RESULTS: In total, 89 women (28.3%) developed CIN2+. High-risk (HR) HPV-positive women developed significantly more CIN2+ than HR-HPV-negative women (cumulative incidence 3.5 years after the index test: 42.2%, 95% CI: 32.5–53.5 for HPV16/18; 36.2%, 95% CI: 28.3–45.4 for other HR-HPV types; and 2.0%, 95% CI: 0.5–7.8 for HR-HPV-negative women; p<0.0001). CONCLUSION: HPV status was of greatest importance in determining the risk of CIN2+. The risk was low among HPV-negative women during the first years of follow-up, suggesting these women could be followed less intensively. HPV16/18-positive women may need intensified follow-up as they showed the highest risk of CIN2+. Public Library of Science 2015-06-17 /pmc/articles/PMC4471160/ /pubmed/26083247 http://dx.doi.org/10.1371/journal.pone.0127444 Text en © 2015 Persson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Persson, Maria
Elfström, K. Miriam
Olsson, Sven-Erik
Dillner, Joakim
Andersson, Sonia
Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title_full Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title_fullStr Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title_full_unstemmed Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title_short Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
title_sort minor cytological abnormalities and up to 7-year risk for subsequent high-grade lesions by hpv type
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471160/
https://www.ncbi.nlm.nih.gov/pubmed/26083247
http://dx.doi.org/10.1371/journal.pone.0127444
work_keys_str_mv AT perssonmaria minorcytologicalabnormalitiesandupto7yearriskforsubsequenthighgradelesionsbyhpvtype
AT elfstromkmiriam minorcytologicalabnormalitiesandupto7yearriskforsubsequenthighgradelesionsbyhpvtype
AT olssonsvenerik minorcytologicalabnormalitiesandupto7yearriskforsubsequenthighgradelesionsbyhpvtype
AT dillnerjoakim minorcytologicalabnormalitiesandupto7yearriskforsubsequenthighgradelesionsbyhpvtype
AT anderssonsonia minorcytologicalabnormalitiesandupto7yearriskforsubsequenthighgradelesionsbyhpvtype